NCT01196039View on ClinicalTrials.gov

A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO)

PHASE2CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

January 31, 2012

Conditions

Asthma

Interventions

DRUG

MEMP1972A

Intravenous repeating dose

DRUG

placebo

Intravenous repeating dose

Trial Locations (7)

T2N 4Z6

Calgary

T6G1Z1

Edmonton

V5Z 1M9

Vancouver

L8N 3Z5

Hamilton

G1V 4G5

Ste. Foy

S7N 0W8

Saskatoon

S-14186

Stockholm

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY